Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamiparib maintenance versus placebo in advanced or metastatic gastric cancer after response to first-line platinum chemotherapy
2017-003493-13Phase 2Unknown
- Sponsor
- BeiGene
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in gastric cancer (GC) comparing Pamiparib maintenance with Placebo maintenance (2 arms). Primary endpoint: Progression-free survival. Status: unknown.
02
Drugs
pamiparib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on 2017-003493-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003493-13.